<DOC>
	<DOCNO>NCT02861846</DOCNO>
	<brief_summary>Beyond 60 year , prevalence epilepsy estimate approximately 1 % increase age . In patient , etiology epilepsy unknown 25 % case , even 55 % 65 year . Although new-onset epilepsy elderly associate vascular disease 50 % case , hypothesis ongoing neurodegenerative process , include Alzheimer 's disease ( AD ) , also common . However , investigator marker might help identify patient develop epilepsy 60 year might , despite normal cognitive functioning , already engage pathophysiological process AD . A number data suggest link pathophysiological process AD epileptogenesis : ( ) third patient epilepsy develops MA , ( ii ) occurrence epilepsy AD aggravating factor cognition , ( iii ) animal model AD , relationship neuronal hyperexcitability amyloid deposit bidirectional , amyloid protein pro-seizure effect presence epilepsy increase amyloid deposit , ( iv ) model , administration antiepileptic drug protects deterioration cognition , ( v ) close relationship amyloid neuronal hyperexcitability might mediate inflammatory process associate AD , particularly microglial activation role epileptogenesis show elsewhere . Investigators hypothesize subgroup patient develop epilepsy 60 year , occurrence epilepsy might reflect presence ongoing amyloid pathology . Our goal identify biomarkers AD cerebrospinal fluid patient develop epilepsy 60 year normal MRI normal cognition high risk later develop clinically define AD . Identifying patient amyloid pathology would express epilepsy onset cognitive dysfunction might help adapt management seizure cognitive dysfunction .</brief_summary>
	<brief_title>Predictive Value Biomarkers Alzheimer 's Disease ( AD ) Elderly Patients With New-onset Epilepsy</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<criteria>Age ≥ 60 year Patients newly diagnose epilepsy accord late criterion International League Epilepsy . MMSE ≥ 28/30 . Patients without cognitive complaint . Patients whose brain MRI reveal significant abnormality outside slight cortical atrophy . Patients lumbar puncture reveal abnormality suggestive infectious disease limbic encephalitis . Patient adequate visual auditory skill , oral write language French available clinical neuropsychological assessment . Patient give write consent . Previous history epilepsy age 60 year . Patient againstindication MRI ( pacemaker , ferromagnetic clip , mechanical heart valve , intracochlear implant , intraocular foreign body , skin ) refuse MRI . Presence abnormality brain MRI . Patients diagnostic criterion dementia Alzheimer 's disease , vascular dementia , mixed dementia frontotemporal lobar degeneration . Patients autoimmune encephalitis . Patients legal protection measure</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>epilepsy</keyword>
	<keyword>Alzheimer</keyword>
	<keyword>biomarkers</keyword>
	<keyword>predictive value</keyword>
</DOC>